Therapeutic advances demand accurate typing of amyloid deposits
- 1 August 2001
- journal article
- Published by Elsevier in The American Journal of Medicine
- Vol. 111 (3) , 243-244
- https://doi.org/10.1016/s0002-9343(01)00774-4
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Search for intermediate structures in transthyretin fibrillogenesis: soluble tetrameric Tyr78Phe TTR expresses a specific epitope present only in amyloid fibrilsJournal of Molecular Biology, 2000
- Liver transplantation for hereditary transthyretin amyloidosisLiver Transplantation, 2000
- Curative hepatorenal transplantation in systemic amyloidosis caused by the Glu526Val fibrinogen α‐chain variant in an English familyQJM: An International Journal of Medicine, 2000
- Myeloablative chemotherapy with stem cell rescue for the treatment of primary systemic amyloidosis: a status reportBone Marrow Transplantation, 2000
- The Systemic AmyloidosesNew England Journal of Medicine, 1997
- Transthyretin mutations in health and diseaseHuman Mutation, 1995
- Occurrence of monoclonal components in general practice: Clinical implicationsEuropean Journal of Haematology, 1992
- Restricted electrophoretic heterogeneity of immunoglobulin light chains in urine: a cause for confusion with Bence Jones proteinClinical Chemistry, 1991